| Timothy Wayne Danielson, RPH | |
|
4433 Vanguard Dr, Sheboygan, WI 53083-6067 | |
| (920) 459-9470 | |
| Not Available |
| Full Name | Timothy Wayne Danielson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 4433 Vanguard Dr, Sheboygan, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992304067 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 8932-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Wayne Danielson, RPH 636 County Highway H, Fredonia, WI 53021-9610 Ph: (262) 343-1417 | Timothy Wayne Danielson, RPH 4433 Vanguard Dr, Sheboygan, WI 53083-6067 Ph: (920) 459-9470 |
News Archive
The findings of a scientific conference examining the growing body of research and potential health benefits of S-equol were published this month in the Journal of Nutrition. Manuscripts based on presentations made at the conference, which was organized by the Life Sciences Research Office, reveal data that S-equol is a safe, natural and effective solution to providing relief of menopausal symptoms such as hot flashes and muscle discomfort.
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., the technology transfer arm of the Hebrew University, introduces a novel method for detecting retinal micro-aneurysms that pose a high risk for leakage, an underlying cause of diabetic retinopathy.
The Center for Global Health Policy's "Science Speaks" blog interviews Kenneth Mayer, founding medical research director of Fenway Health, as part of its "Blueprint" series, which examines issues surrounding the creation of a blueprint for an AIDS-free generation commissioned by Secretary of State Hillary Clinton in July.
In a recent bioRxiv* preprint, the large team of researchers evaluated a SARS-CoV-2 Spike receptor-binding domain ferritin nanoparticle protein vaccine (RFN) in a nonhuman primate challenge model. This study addresses the need for a next-generation, efficacious vaccine with an increased pan-SARS breadth of coverage.
› Verified 9 days ago
Mr. Lawrence J Mihalevich, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1029 N 14th St, Sheboygan, WI 53081 Phone: 920-458-7707 | |
Mary Miller, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1317 N 25th St, Picknsave Pharmacy 6432, Sheboygan, WI 53081 Phone: 920-457-5839 Fax: 920-457-5853 | |
Christa Wilson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 Saemann Ave, Sheboygan, WI 53081 Phone: 920-783-6633 | |
Judith L Lukach, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3529 Superior Ave, Sheboygan, WI 53081 Phone: 920-459-2755 | |
Matthew Wilke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3529 Superior Ave, Sheboygan, WI 53081 Phone: 920-459-2755 | |
Dr. David Roth, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1108 N 14th St, Sheboygan, WI 53081 Phone: 920-452-0079 | |
Tou Lee Xiong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1029 N 14th St, Sheboygan, WI 53081 Phone: 920-458-7707 |